Cargando…

Response to Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130–2134

Detalles Bibliográficos
Autores principales:	Sukumar, Piruthivi, Kearney, Mark T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Online Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837046/ https://www.ncbi.nlm.nih.gov/pubmed/24264411 http://dx.doi.org/10.2337/db13-1392

Ejemplares similares

Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130–2134
por: Jandeleit-Dahm, Karin A.M., et al.
Publicado: (2013)

Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction
por: Sukumar, Piruthivi, et al.
Publicado: (2013)

Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Gylfe, Erik
Publicado: (2013)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Schalkwijk, Casper G., et al.
Publicado: (2013)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Yamagishi, Sho-ichi
Publicado: (2013)

Response to Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Hardy, Alexandre B., et al.
Publicado: (2013)

Response to Comments on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Comment on: Lazo et al. NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes. Diabetes 2013;62:3189–3193
por: Moro, Cedric, et al.
Publicado: (2013)

Comment on: Sitnick et al. Skeletal Muscle Triacylglycerol Hydrolysis Does Not Influence Metabolic Complications of Obesity. Diabetes 2013;62:3350–3361
por: Moro, Cedric, et al.
Publicado: (2013)

Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Response to Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708
por: Tessari, Paolo
Publicado: (2013)

Comment on: Korpos et al. The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human. Diabetes 2013;62:531–542
por: Simeonovic, Charmaine J., et al.
Publicado: (2013)

Response to Comment on: Korpos et al. The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human. Diabetes 2013;62:531–542
por: Korpos, Éva, et al.
Publicado: (2013)

Comment on: Takeda et al. Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice. Diabetes 2013;62:223–233
por: Chhabra, Kavaljit H., et al.
Publicado: (2013)

Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
por: Maqbool, Azhar, et al.
Publicado: (2020)

Response to Comment on: Takeda et al. Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice. Diabetes 2013;62:223–233
por: Yamamoto, Koichi, et al.
Publicado: (2013)

The NADPH Oxidase Nox4 and Aging in the Heart
por: Ago, Tetsuro, et al.
Publicado: (2010)

Knock out of the NADPH oxidase Nox4 has no impact on life span in mice
por: Rezende, Flavia, et al.
Publicado: (2016)

Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Heine, Robert J., et al.
Publicado: (2013)

Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Engel, Samuel S., et al.
Publicado: (2013)

Reponse to Comments on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Butler, Alexandra E., et al.
Publicado: (2013)

NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction
por: Taylor-Fishwick, David A.
Publicado: (2013)

The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis
por: Sorce, Silvia, et al.
Publicado: (2014)

Structure of the core human NADPH oxidase NOX2
por: Noreng, Sigrid, et al.
Publicado: (2022)

Systemic regulation of the age-related decline of pancreatic β-cell replication. Diabetes 2013;62:2843–2848
por: Salpeter, SJ, et al.
Publicado: (2013)

Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme
por: Katsuyama, Masato, et al.
Publicado: (2012)

The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
por: Altenhöfer, Sebastian, et al.
Publicado: (2012)

The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
por: Liang, Shuang, et al.
Publicado: (2016)

Function of NADPH Oxidases in Diabetic Nephropathy and Development of Nox Inhibitors
por: Lee, Sae Rom, et al.
Publicado: (2020)

Implication of type 4 NADPH oxidase (NOX4) in tauopathy
por: Luengo, Enrique, et al.
Publicado: (2021)

NOX Family NADPH Oxidases: Do They Have Built-in Proton Channels?
por: Maturana, Andrés, et al.
Publicado: (2002)

Expression of NADPH Oxidase (NOX) 5 in Rabbit Corneal Stromal Cells
por: Rizvi, Farhan, et al.
Publicado: (2012)

Identification of Small Peptides that Inhibit NADPH Oxidase (Nox2) Activation
por: Fisher, Aron B., et al.
Publicado: (2018)

On the mechanism of calcium‐dependent activation of NADPH oxidase 5 (NOX5)
por: Millana Fañanás, Elisa, et al.
Publicado: (2019)

Structure, regulation, and physiological functions of NADPH oxidase 5 (NOX5)
por: García, Jorge G., et al.
Publicado: (2023)

Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase‐induced cardiomyopathy: involvement of mitofusin‐2
por: McLaughlin, Declan, et al.
Publicado: (2017)

Erratum. The Effects of Type 2 Diabetes on Lipoprotein Composition and Arterial Stiffness in Male Youth. Diabetes 2013;62:2958–2967
por: Gordon, Scott M., et al.
Publicado: (2016)

NOX2β: A Novel Splice Variant of NOX2 That Regulates NADPH Oxidase Activity in Macrophages
por: Harrison, Craig B., et al.
Publicado: (2012)

The NADPH oxidase Nox4 restricts the replicative lifespan of human endothelial cells
por: Lener, Barbara, et al.
Publicado: (2009)

Cellular and temporal expression of NADPH oxidase (NOX) isotypes after brain injury
por: Cooney, Sean J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pe051ne83infqcb94b9ufk1her